Carvedilol: something else than a simple betablocker?

نویسندگان

  • A Palazzuoli
  • P Calabria
  • M S Verzuri
  • A Auteri
چکیده

Carvedilol is a cardiovascular drug of multifaceted therapeutic potential, with beta-blocker and vasodilatative activity. These actions confer to the above mentioned betablocker some beneficial properties on several processes involving cardiovascular system. Carvedilol provides haemodynamic, antiischemic, antiproliferative and antiarrhytmic benefits, for its antioxidant neurohumoral and electrophysiological effects. All these actions provide the basis for usefulness of the drug in the treatment of hypertension, coronary heart disease, and congestive heart failure. In this review we report the beneficial properties of Carvedilol and we analyze the rational clinical use of this betablocker taking special attention on recent clinical trial in heart failure where it appears an evidence supporting an important, favourable effect of the drug.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The left ventricular diastolic function as prognostic predictor in patients with idiopathic dilated cardiomyopathy 7

Background: Previous studies have demonstrated that the presence of restrictive left ventricular (LV) diastolic filling pattern in patients with dilated cardiomyopathy have an unfavorable prognostic. Aim: 1. To establish the value of LV diastolic filling pattern as prognostic predictor in patients with idiopathic dilated cardiomyopathy. 2. Assessment of the betablocker treatment on these patien...

متن کامل

Pharmacologic stress echocardiography: can we forget "state-of-the-art" protocols?

acteristics. Furthermore, to avoid a basic misunderstanding of the objective of our study, one specific point needs to be emphasized. The study was not designed to address the question of whether one betablocker is more effective than another, but rather (as clearly stated in our article) to evaluate whether carvedilol may provide additional benefits in a select subgroup of patients with dilate...

متن کامل

Immunadsorption therapy for end stage heart failure due to Duchenne muscular dystrophy

We report about a successful immunadsorption therapy of a boy with end stage heart failure due to Duchenne muscular dystrophy who has little chance to get cardiac transplantation. Prior to this therapy a medical therapy with an angiotensin converting enzyme inhibitor, a low dose betablocker, an aldosterone antagonist, and diuretics failed. In consent with the patient and his parents immunoadsor...

متن کامل

Replacement of carvedilol for propranolol in patients with heart failure.

BACKGROUND Large clinical trials using the betablockers carvedilol, metoprolol, bisoprolol and nebivolol have demonstrated improvement of survival and symptoms in patients with heart failure. Despite the lack of scientific evidence, it is plausible that their beneficial effects are extensible to other betablockers. OBJECTIVE To evaluate the impact of the replacement of carvedilol for proprano...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • European review for medical and pharmacological sciences

دوره 6 6  شماره 

صفحات  -

تاریخ انتشار 2002